WELLS FARGO & COMPANY/MN

Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in CRBP

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$412

+$54 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $1,293,431,965 across 386 Biotechnology names. CRBP ranks #343 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	744,995	$332,670,066
2	ALNY	Alnylam Pharmaceuticals, Inc.	342,763	$113,409,991
3	REGN	Regeneron Pharmaceuticals, Inc.	142,021	$109,731,102
4	HALO	Halozyme Therapeutics, Inc.	1,535,737	$99,254,679
5	INSM	INSMED Inc	597,384	$97,684,229
6	ASND	Ascendis Pharma A/S	154,199	$35,269,936
7	EXEL	Exelixis, Inc.	687,304	$29,478,466
8	ARGX	Argenx SE	38,104	$27,825,444

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$412	44	0.0%	Shares	Defined	2026-05-11
2025-12-31	$358	44	+4300.0%	Shares	Defined	2026-02-13
2025-09-30	$12	1	-99.6%	Shares	Defined	2025-11-13
2025-06-30	$1,731	251	-96.2%	Shares	Defined	2025-08-14
2025-03-31	$35,300	6,648	+3.2%	Shares	Defined	2025-05-13
2024-12-31	$76,038	6,444	+51.7%	Shares	Defined	2025-02-13
2024-09-30	$87,656	4,249	-8.3%	Shares	Defined	2024-11-13
2024-06-30	$209,643	4,633	+328.6%	Shares	Defined	2024-08-13
2024-03-31	$42,418	1,081	+3079.4%	Shares	Defined	2024-05-10
2023-12-31	$205	34	-94.5%	Shares	Defined	2024-02-09
2023-09-30	$4,144	615	+668.8%	Shares	Defined	2023-11-13
2023-06-30	$627	80	+1.3%	Shares	Defined	2023-08-15
2023-03-31	$573	79	—	Shares	Defined	2023-05-12
No filing history on record for this holder in this stock.